Hormel Foods Corp vs Inovio Pharmaceuticals Inc — how do they compare? Hormel Foods Corp trades at $25.19 (market cap $13.91B), while Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M). The key difference: Hormel Foods Corp is far larger — about 155.8× Inovio Pharmaceuticals Inc's market cap, and Hormel Foods Corp pays a 4.63% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| HRL | INO | |
|---|---|---|
Market Cap | $13.91B | $89.27M |
Sector | Consumer Staples | Health |
52-Week High | $29.52 | $2.87 |
52-Week Low | $19.74 | $1.05 |
Enterprise Value | $15.91B | $60.28M |
Dividend Yield | 4.63% | — |
Trailing returns across standard periods
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →